GURUFOCUS.COM » STOCK LIST » USA » NAS » ZimVie Inc (NAS:ZIMV) » Definitions » ROCE %
Switch to:

ZimVie ROCE %

: -8.10% (As of Mar. 2022)
View and export this data going back to 2022. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ZimVie's annualized ROCE % for the quarter that ended in Mar. 2022 was -8.10%.


ZimVie ROCE % Historical Data

The historical data trend for ZimVie's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21
ROCE %
- -1.44 -12.16 -6.00

ZimVie Quarterly Data
Dec18 Dec19 Dec20 Mar21 Sep21 Dec21 Mar22
ROCE % Premium Member Only Premium Member Only 1.17 -0.01 - -16.10 -8.10

ZimVie ROCE % Calculation

ZimVie's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=-101/( ( (1949.2 - 226.2) + (1826.7 - 184.6) )/ 2 )
=-101/( (1723+1642.1)/ 2 )
=-101/1682.55
=-6.00 %

ZimVie's ROCE % of for the quarter that ended in Mar. 2022 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2022 )  (Q: Dec. 2021 )(Q: Mar. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2022 )  (Q: Dec. 2021 )(Q: Mar. 2022 )
=-129.472/( ( (1826.7 - 184.6) + (1774.265 - 219.549) )/ 2 )
=-129.472/( ( 1642.1 + 1554.716 )/ 2 )
=-129.472/1598.408
=-8.10 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZimVie  (NAS:ZIMV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


ZimVie ROCE % Related Terms

Thank you for viewing the detailed overview of ZimVie's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


ZimVie Business Description

ZimVie logo
Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions.
Executives
Crawford Sally director C/O HOLOGIC, INC. BEDFORD MA 01730
Kuntz Richard director MEDTRONIC, INC. 710 MEDTRONIC PWKY MS LC 310 MINNEAPOLIS MN 55432
Asar Vinit K director 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758
Matusinec Karen director C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
King David P director PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203
Zimmer Biomet Holdings, Inc. 10 percent owner 345 EAST MAIN STREET WARSAW IN 46580
Whitney Rebecca Ann officer: See Remarks 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Harmon David John officer: See Remarks 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Jamali Vafa director, officer: See Remarks C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Kanaglekar Indraneel officer: See Remarks C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Kidwell Heather officer: See Remarks C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Schneider Sandra officer: Chief Accounting Officer C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Heppenstall Richard officer: See Remarks C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)